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Self-tests for HIV in South Africa are currently unregulated. Gaps in 
law and policy have created a legal loophole where such tests could 
effectively be sold in supermarkets, but not in pharmacies. At the 
same time, South Africa lacks an effective regulating mechanism for 
diagnostic tests, which brings the quality and reliability of all self-tests 
into question. The authors argue for greater access to, and availability 
of, quality HIV self-tests. This strategy will encourage regular HIV 
testing, allay fears about stigma and confidentiality when testing in 
public facilities, and decrease the costs associated with traditional 
voluntary counselling and testing, and is likely to lead to earlier 
diagnosis and treatment of HIV.
The South African Medical Association (SAMA) recently warned 
the public against using HIV self-testing kits. SAMA chairman 
Norman Mabasa noted that it was ‘risky’ for individuals to test 
themselves ‘unmonitored’ and that it might lead to devastated patients 
or suicide.1-3 These warnings were subsequently echoed by members 
of the national Department of Health and the Treatment Action 
Campaign.4 Objections included questions about the accuracy of the 
tests, lack of support systems and pre- and post-test counselling, the 
inability to always be able to confirm the results by a second test, and 
the dangers of misinterpretation of the results.1,2,4 SAMA expressed 
similar objections in 2005 when the supermarket chain store Pick ’n 
Pay explored selling self-testing kits for HIV at its outlets.5  The Pick 
’n Pay launch was subsequently cancelled.6 Yet, during that time, HIV 
self-tests were available over the counter (OTC) from a number of 
pharmacies at prices that ranged from R40 to R60 per test.
A number of other OTC self-tests are available from the Dis-Chem 
pharmacy chain (Table I), while some of these were also available 
at the Clicks pharmacy chain and other local pharmacies. Neither 
Clicks nor Dis-Chem pharmacy chains stocked HIV self-tests at the 
time of writing, but the extent to which these are currently provided 
by community pharmacies is unknown. The objections that SAMA 
raised against HIV self-tests could apply equally to other self-tests, 
yet the distribution of such tests is not regulated. Other diagnoses 
may be as devastating, or might have been in the past. A diagnosis 
of type 1 diabetes, for instance, was a certain death sentence 
before there was widespread access to insulin. Such access is not 
yet universal. Pregnancy testing might also be considered to pose 
risks, in the absence of access to suitable professional advice. Cancer 
remains a dreaded diagnosis, and there are serious ethical concerns 
surrounding testing for ‘recreational’ drugs.
What is it about HIV/AIDS in 2010 that encourages medical, ethics 
and activist bodies to respond to HIV self-diagnosis with such alarm 
and conservatism?
HIV testing models
The term ‘AIDS exceptionalism’ was coined in the early 1990s to 
describe an approach to the AIDS epidemic that was explicitly 
located within a human rights and bioethics framework.7-11 This 
approach to HIV/AIDS led to a novel methodology in the diagnosis 
of HIV: voluntary counselling and testing (VCT). VCT includes 
pre- and post-test counselling, express and informed consent that an 
HIV test would be conducted on the patient, and assurances of the 
confidentiality of the test result.12
With the advent of highly active antiretroviral treatment and 
subsequent increased access to such treatment, a number of authors 
started questioning the ongoing relevance and appropriateness of 
‘AIDS exceptionalism’. Proponents of the ‘normalisation of AIDS’ 
argue that it will decrease the stigma associated with the epidemic, 
remove barriers to testing, increase access to treatment, and change 
societal perceptions of HIV/AIDS.11,13-15 There was a call for the 
rapid scale-up of HIV testing after the WHO/UNAIDS 3x5 initiative 
(treating 3 million people by 2005) was launched in 2003.16-18 After 
substantial controversy and debate, the WHO/UNAIDS-endorsed 
‘provider-initiated testing and counselling’ (PITC) model was 
introduced to scale up the number of people who know their HIV 
status. The PITC approach moves away from VCT by emphasising the 
health care provider’s role in recommending an HIV test to patients 
and providing ‘pre-test information’ (not counselling). An HIV test 
would generally be performed unless the patient declines.19 South 
Africa’s National Strategic Plan and various authors recommend this 
approach.20,21 A change to current testing practices, that has been 
termed HIV counselling and testing (HCT), was introduced in the 
2010 guidelines, but no policy has been passed.22,23
New or alternative approaches to HIV testing include: (i) models 
that make subtle changes to the traditional VCT model, such as 
mobile VCT centres, routine offer of VCT,24 home-based VCT;25 
(ii) providing monetary or other incentives to individuals to test;26 
(iii) home-based HIV testing where the individual sends a dry-spot 
test to a laboratory and the results are relayed telephonically and 
anonymously;27 (iv) self-testing;27,28 and (v) mandatory testing during 
pregnancy29 or for deployment of soldiers to conflict areas.30 The Corresponding author: M Richter (marlise.richter@gmail.com)
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Table I. Self-tests (price in parentheses) available from Dis-
Chem pharmacy without a prescription in 2009
•   Pregnancy test (R26)
•   Prostate cancer test (R44)
•   Ovulation test (R94)
•   Test for five separate ‘recreational’ drugs (R73) 
•   Breathalysers for alcohol (R415)
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majority of these testing models involve a third party (a counsellor, 
nurse or physician) and make it near-impossible for a person to test 
for HIV without counselling.
State of HIV testing in South Africa
HIV testing has escalated dramatically in South Africa over the last 
few years, this escalation driven by the Department of Health, non-
governmental and donor programmes, and the insurance industry. 
The 2008 HSRC Household Survey showed a significant increase in 
the number of people who knew their HIV status.31 In the 2002 HSRC 
survey, only 21.4% of people over the age of 15 years had had an HIV 
test in their lifetime, compared with 30.5% in 2005, and 50.8% in 
2008. Almost a quarter (24.7%) of people aged 15 - 49 years had had 
an HIV test in the preceding 12 months in 2008. The 2008 survey 
highlighted once again the important gender differences in HIV 
testing: significantly more women (28.7%) received an HIV test in the 
last 12 months and knew their results than men (19.8%).31 The survey 
encouraged further initiatives to increase uptake of testing.
Current legal and policy analysis
It is clear that HIV testing needs to be expanded in South Africa, and 
that people should regularly retest. Self-testing for HIV could aid 
this process. Would HIV self-tests be possible under current South 
African law and policy?
Legal considerations
Self-tests for HIV should fall under the definition of a ‘medical 
device’ in the Medicines and Related Substances Control Act (Act 101 
of 1965, as amended) and should be regulated by this Act. However, 
no mechanism for the registration of medical devices currently exists. 
Some medicated devices (such as drug-impregnated stents) have been 
registered as ‘medicines’, but diagnostic tests remain unregulated. 
The Medicines and Related Substances Amendment Act (Act 72 
of 2008) attempted to remedy this situation by simply replacing 
the term ‘medicine’ throughout the Act with the term ‘product, 
medical device or IVD (in vitro diagnostic)’. This Act has not yet 
been promulgated. The practicality of applying the same registration 
process for medicines to all medical devices, which range from large-
scale imaging systems to disposable test kits, is questionable. There is 
currently no restriction on where such diagnostic tests may be sold 
or to whom. The only legally binding restriction on the distribution 
of self-testing HIV kits is provided by the Good Pharmacy Practice 
(GPP) standards issued by the South African Pharmacy Council. 
These are discussed below.
The National Health Act (Act 61 of 2003) will replace the Human 
Tissue Act (Act 65 of 1983) but has not yet been brought into effect 
in its entirety. Section 68(1)(h) of the Act makes provision for the 
Minister of Health to enact regulations on ‘the withdrawal of blood 
from living persons and the preservation, testing, processing, supply 
or disposal of withdrawn or imported blood’. Section 68 was brought 
into effect on 17 May 2010;32 the accompanying regulations33 enabled 
persons who are not health care providers, but who had received at 
least three hours of training at a health establishment, to withdraw a 
‘small quantity of capillary blood sufficient for testing’. Although this 
enables lay counsellors to be used in HIV testing, it does not preclude 
patients, such as diabetics, from withdrawing their own capillary 
blood using suitable equipment.
Policy
The Department of Health published the National Policy on Testing 
for HIV in 2000,34 which provides for the conditions under which 
HIV tests can be conducted in health care facilities, and is based on 
the traditional VCT model. It is silent on self-tests. South Africa’s 
national AIDS policy – the National Strategic Plan 2007 - 2011 – 
provides new directions for HIV testing in South Africa; it tasks 
the Department of Health with development of ‘new strategies for 
the provision of counselling and testing outside of health facilities’.21 
Although the 2010 clinical guidelines make reference to an ‘HCT 
policy’, no such policy has been issued. A new guideline currently 
before the South African National AIDS Council (SANAC) is 
intended to guide practitioners on HIV testing, but current drafts 
suggest conventional approaches to testing and counselling processes 
and have also not been finalised.35
Guidelines
The minimum conditions for screening and testing by pharmacies are 
provided in the GPP standards issued by the South African Pharmacy 
Council.36 Section 2.13.5.8(h) of the GPP is unequivocal that ‘[p]harma- 
cists must not sell HIV tests for patients to perform at home’.36 This 
injunction does not apply to any other monitoring tests. The GPP 
notes that the Medicines Control Council does not register HIV tests, 
and it recommends that these tests should only be purchased from 
‘reputable companies’ and when such tests had been registered ‘in the 
country of origin’.
The Health Professions Council of South Africa guidelines on 
‘The management of patients with HIV infection or AIDS’ mention 
self-testing in relation to potential abuse of such tests. This document 
advises that people who want to utilise self-tests should enquire from 
their doctor on their reliability and safety. The guidelines make it 
clear that new forms of testing ‘should only be adopted if it conforms 
with the guidelines’ – thus effectively endorsing existing health care 
professional-controlled methods such as VCT.
Arguments against self-testing for 
HIV
A number of arguments have been levelled against self-testing; they 
are briefly discussed below.
There is increased risk of unmanaged anxiety, 
with potential for suicide
The risk certainly exists that the user of a self-test may be traumatised 
by the test result; yet the same holds true for other conditions, 
such as pregnancy and cancer, that can be diagnosed by currently 
available self-tests. Pregnancy is a sexually transmitted condition 
with profound and lifelong implications that may lead to stigma and 
suicide. There is no move to halt the distribution of these tests (widely 
available in supermarkets), as weighing the benefits of knowing one’s 
pregnancy status against possible social harms seems relatively easy. 
Merson and colleagues point out that, although suicide and suicidal 
ideation can occur after a positive HIV diagnosis, the available 
evidence shows that suicide only really becomes a concern when 
AIDS-related symptoms develop.27
Counselling is a vital component of HIV tests 
and is bypassed by self-testing
Our own experience – from undergoing counselling personally, 
providing it and/or running programmes that provide this service 
– is that the quality and applicability of counselling in South Africa 
is extremely variable. At its best, counselling provides information, 
manages anxiety, and refers people to appropriate care. At worst, it 
is culturally inappropriate, increases anxiety and misinformation, 
and leaves patients devastated and disempowered, with no link to 
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health or other follow-up systems. While the potential benefits of 
counselling are acknowledged, it should never constitute a barrier to 
people who want to ascertain their HIV status, but do not want to be 
counselled.
Testing could be coerced in a home 
environment
Risk of coercion (forced testing) arises with a number of self-tests, 
including pregnancy and drug tests. We are not aware of any available 
data on the incidence of such coercive testing in South Africa. HIV 
self-tests might have been available from some outlets, and no 
reports of abuse of these tests have appeared. South Africa has an 
extensive HIV-related legal framework in place. Legislation such as 
the Employment Equity Act and the National Health Act, as well 
as common law, should provide ample protection against potential 
abuse. Indeed, various authors have pointed out that potentially 
beneficial technology should not be prohibited because there is a 
chance that it could be abused.14,37
Accuracy of test
Opposition against self-testing has relied heavily on the claim that 
self-tests could be inaccurate and should therefore not be available 
to the public. The Food and Drug Administration (FDA) in the USA 
approved the first HIV self-testing kit in 1996.25 Diagnostic testing 
technology has improved since the late 1990s. Nonetheless, South 
Africa lacks an effective regulating mechanism for all diagnostic 
tests – not just HIV tests. This legal loophole is one more reason to 
ensure that the appropriate frameworks be put into place so that all 
diagnostic tests, including self-tests, are thoroughly tested, approved 
and appropriately regulated.
In summary, the arguments against self-testing are largely based on 
vague fears with little or no evidence to support them. It would seem 
sensible to provide increased access to HIV testing in a facilitatory 
way, encouraging people to access care in a way that suits them, 
rather than based on a model that encourages unnecessary ‘AIDS 
exceptionalism’38 and fear-mongering. Indeed, self-testing may reach 
groups that have been traditionally hard to reach with general public 
health campaigns,39 and would be in line with the spirit of the Patients 
Rights Charter and the National Health Act, that both encourage 
people to take responsibility for their own health.
Recommendations
We believe that self-testing should be made widely available in South 
Africa, and offer the following recommendations to this end:
•    The current legal and policy framework should be amended to 
include specific provisions on self-testing kits and to remove 
all provisions that would prohibit their distribution. Once the 
South African Health Products Regulatory Authority is in place, 
a suitable regulatory system for all diagnostic tests, including self-
tests for HIV, needs to be created.
•    The information sheet in a self-testing kit should contain detailed 
but simple information on HIV testing with an emphasis on 
explaining the window period and the importance of confirming 
a positive HIV result at a clinic or hospital where appropriate HIV 
management could be offered.
•    Self-testing kits should clearly display the accuracy of the test and 
emphasise the importance, in unambiguous language, of the need 
for a confirmatory test of a positive result.
•    The information sheet in the testing kits should recommend that 
the user contact a toll-free helpline for counselling and assistance 
when taking the test. Existing telephone helplines (such as the 
National AIDS Helpline and LifeLine) should expand their 
services to include counsellors who have been trained to counsel 
people who conduct home tests, and can make the necessary 
referrals.
•    Clear warnings should be displayed on the pack that it is illegal to 
test other people for HIV, while providing links to legal support 
and advice organisations.
Conclusion
The sentiments expressed by the medical establishment, activists and 
the Department of Health seem poorly thought through, especially 
when measured against existing practice in areas other than HIV. 
At present, it would seem that there is no legal impediment to 
supermarkets selling HIV self-testing kits, but that the GPP prohibits 
the sale of such tests only in pharmacies, notwithstanding which 
there is no mechanism in place to regulate the quality and reliability 
of self-tests; this situation should be addressed urgently.
We believe that the availability of accurate home-based tests will 
increase access to HIV testing – especially for individuals who have 
fears about stigma and confidentiality when testing in public facilities 
– will remove some of the burden of the ‘worried well’ from the public 
and private health system, and will encourage regular testing within 
the general population. It is foreseeable that self-testing would lead to 
earlier diagnosis of HIV status and earlier enrolment into treatment, 
and decrease the costs associated with traditional VCT.38 South Africa 
has reached a point in its AIDS epidemic where individuals should be 
able to decide when and where they would like to test for HIV, and do 
so without having to involve anyone else.
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While there are no specific protocols for dealing with reports of 
sexual abuse of children, the Criminal Law (Sexual Offences and 
Related Matters) Amendment Act of 2007 (Act No. 32 of 2007) clearly 
stipulates that, in the event of a report of sexual abuse by a child or 
any other person of the abuse of a child, the relevant person has the 
legal (statutory) obligation to report such abuse to the police; and 
that it replaces previous legislation where reporting could be done 
to a social worker or the police. According to the Child Advocate, a 
disclosure by a child (specific child, specific offender) is sufficient to 
require such reporting.
Given this statutory requirement, research with children that 
focuses on children’s sexuality and reproductive health is likely to 
encounter instances of abuse of children. According to the Act, a 
child is any person below the age of 18; but with reference to Sections 
15 and 16 of the Act, it refers also or specifically refers to any person 
below the age of 16. In this report, all ages up to 17 are referenced 
as children. To adequately address the response of this requirement 
within a research context, where the involvement of law enforcement 
can easily jeopardise the research, the following standard operating 
practice is recommended:
1.    Any child of 17 years or younger who reports abuse (as defined 
in the Act), or on whose behalf abuse is reported by a peer, care Corresponding author: A Bhana (abhana@hsrc.ac.za)
The authors are researchers in the Human and Social Development 
and HIV/AIDS, STIs and TB Research Programmes of the Human 
Sciences Research Council (HSRC), and are members of the HSRC 
Ethics Committee.
MEDICINE AND THE LAW
Standards for the reporting of sex/sexual activity of minors in a 
research context
Arvin Bhana, Sharlene Swartz, Adlai Davids
